Turning Point Therapeutics' GAAP loss for 2021 was $236.551 million, up 50.4% from $157.292 million in the prior year. Revenue increased 23.3% to $30.829 million compared to $25 million a year earlier.
Warning BlackTerminal uses cookies in order to personalize and improve the usability of the service. If you do not want to use cookies, please change your browser settings. Accept